Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells
1998

EGFR Activation in Prostate Cancer Cells

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): ER Sherwood, JL Van Dongen, CG Wood, S Liao, JM Koziowski, C Lee

Primary Institution: Northwestern University Medical School

Hypothesis

Does EGFR activation play a functional role in androgen-stimulated growth of prostate cancer cells?

Conclusion

EGFR activation is common in prostatic carcinoma cells but does not contribute to androgen-stimulated growth in LNCaP cells.

Supporting Evidence

  • PC3 and DU145 cells showed higher levels of EGFR expression than LNCaP cells.
  • Normal prostatic epithelial cells did not exhibit detectable levels of EGFR phosphorylation without EGF.
  • EGFR activation was not altered by DHT in LNCaP cells.

Takeaway

This study found that prostate cancer cells often use a growth signal called EGFR to grow, but this signal doesn't help them grow when androgens are present.

Methodology

The study used Western blot analysis, ELISA immunoassays, and immunoprecipitation to assess EGFR expression and activation in various prostate cancer cell lines.

Limitations

The study primarily focused on in vitro conditions, which may not fully represent in vivo tumor behavior.

Participant Demographics

Cell lines included androgen-independent (PC3, DU145) and androgen-responsive (LNCaP) prostate cancer cells, as well as normal prostatic epithelial cells from organ donors under 35 years old.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication